[1]李海良,张克清.参芪复脉汤联合西药治疗慢性心衰疗效及对患者心功能的影响*[J].陕西中医,2019,(2):163-166.
　LI Hailiang,ZHANG Keqing..Effect of Shenqi Fumai decoction combined with western medicine on chronic heart failure and its influence on cardiac function[J].,2019,(2):163-166.
点击复制

参芪复脉汤联合西药治疗慢性心衰疗效及对患者心功能的影响*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2019年2期
页码:
163-166
栏目:
临床研究
出版日期:
2019-02-05

文章信息/Info

Title:
Effect of Shenqi Fumai decoction combined with western medicine on chronic heart failure and its influence on cardiac function
文章编号:
DOI: 10.3969/j.issn.10007369.2019.02.007
作者:
李海良; 张克清
河南省安阳市中医院心病二科（安阳455000）
Author(s):
LI Hailiang; ZHANG Keqing.
Department of Cardiology，Anyang Hospital of Traditional Chinese Medicine(Anyang 455000)
关键词:
慢性心衰; 参芪复脉汤; 心功能; 左心室射血分数; 左室舒张末容积; B型利尿钠肽
Keywords:
Key words Chronic heart failure;  Shenqi Fumai decoction; Cardiac function; LVEF; LVEDV; BNP
分类号:
R541.6
文献标志码:
A
摘要:
摘 要 目的：探讨参芪复脉汤联合西药治疗慢性心衰的疗效及心功能的影响。方法： 选择慢性心衰患者72例，随机分为对照组和观察组各36例。对照组给予琥珀酸美托洛尔加替米沙坦、氢氯噻嗪等西药治疗；观察组在对照组基础上给予中药参芪复脉汤治疗。比较两组临床疗效，观察治疗前后左心室射血分数（LVEF）、左室舒张末容积(LVEDV)、B型利尿钠肽（BNP）、N末端B型利尿钠肽原（NTproBNP）变化及生活质量情况。结果：治疗5、7、14 d后，两组中医证候积分均明显下降，观察组比对照组更明显（P＜0.05）。两组治疗前LVEF、LVEDV 、BNP及NTproBNP水平比较差异无统计学意义（P＞0.05）；治疗后两组LVEF水平均显著升高，LVEDV 、BNP及NTproBNP均显著降低（P＜0.05）；观察组治疗后LVEF水平显著高于对照组，LVEDV 、BNP及NTproBNP显著低于对照组（P＜0.05）。观察组治愈率及总有效率均高于对照组治愈率及总有效率（P＜0.05）。治疗后观察组生活质量评分显著高于对照组（P＜0.05）。两组患者治疗期间均无明显不良反应。结论：参芪复脉汤结合西药可显著改善慢性心衰患者LVEF、BNP及NTproBNP等心功能指标，临床疗效显著，患者预后良好。
Abstract:
Abstract Objective：To explore the effect of Shenqi Fumai decoction combined with western medicine on chronic heart failure and its influence on cardiac function. Methods:72 patients with chronic heart failure were randomly divided into control group (36 cases) and observation group (36 cases). The control group was treated with metoprolol succinate + telmisartan + hydrochlorothiazide and other western medicine；the observation group was treated with Shenqi Fumai decoction on the basis of the control group. The clinical effects of the two groups were compared. The changes of left ventricular ejection fraction (LVEF)，left ventricular end diastolic volume (LVEDV)，Btype natriuretic peptide (BNP)，Nterminal Btype natriuretic peptide (NTproBNP) and quality of life were observed before and after treatment. Results:After 5，7，and 14 days of treatment，the scores of TCM syndromes in both groups were significantly decreased，and the observation group was more obvious than the control group (P＜0.05). There was no significant difference in LVEF，LVEDV，BNP and NTproBNP levels between the two groups before treatment (P＞0.05)；after treatment，the levels of LVEF in both groups were significantly increased，while the levels of LVEDV，BNP and NTproBNP were significantly decreased (P＜0.05).After treatment，the levels of LVEF in the observation group were significantly higher than those in the control group，and LVEDV，BNP and NTproBNP were significantly lower than those in the control group (P＜0.05). The cure rate and total effective rate of the observation group were higher than those of the control group and the total effective rate(P＜0.05). After treatment，the quality of life score of the observation group was significantly higher than that of the control group (P＜0.05). No significant adverse reactions were observed in the two groups during treatment. Conclusion:Shenqi Fumai decoction combined with western medicine can significantly improve LVEF，BNP and NTproBNP in patients with chronic heart failure and other cardiac function indicators，the clinical effect is significant，the prognosis of patients is good. 

参考文献/References:

\[1\] 韩额尔德木图，马月宏，王海燕,等. 慢性心衰的病理生理及发病机制研究进展[J] . 中西医结合心脑血管病杂志，2016，14(12):13491352.
[2] 王佳涛. 慢性心力衰竭并贫血患者铁调节素、血清转铁蛋白受体、肿瘤坏死因子α、白介素6的水平及意义[J] . 贵州医药，2016，40(5):480481.
[3] 杨禹娟，张 勇，吕 军,等. 益气复脉注射液治疗老年冠心病并发慢性心力衰竭30例[J] . 陕西中医，2016，37(10):13251326.
[4] 季红慧，罗秀英. 血浆标志物与慢性心力衰竭患者急性心力衰竭发作及肾功能异常的关系研究[J] . 浙江医学，2016，38(12):943945.
[5] 李秀芬,杨敏全,帕尔哈提·吐尔逊.急性冠状动脉综合征负荷量替格瑞洛诱发急性左心衰竭8例[J] .中国循环杂志,2017,32(12):1234.
[6] 《慢性心力衰竭中医诊疗专家共识》解读[J] .临床合理用药杂志,2015,8(9):149.
[7] 韩额尔德木图，孟永梅. 148例慢性心衰中医主要证候要素与理化指标的研究[J] . 中医药学报，2016，44(3):5460. 
[8] 全振华，艾 民，金 娟,等. 芪苈强心胶囊对慢性心衰的治疗作用及机制的研究进展[J] . 中医药学报，2016，44(2):108110.
[9] 万 洁，林 谦，苏敬泽,等. 慢性心力衰竭中西医结合生活质量量表标准效度评价[J] . 中国中西医结合杂志，2016，36(11):13001303.〖ZK)〗
[10] 宋 韵，闫 伟，任 骞. 心脏康复运动对慢性心力衰竭患者预后的影响[J] . 陕西医学杂志，2017，46(2):241242. 
[11] 郭慧佳，张建义，胡亚军,等. 高敏肌钙蛋白T与慢性心力衰竭的相关性及对急性心肌梗死的鉴别意义[J] . 中国现代药物应用，2017，33(10):871874.
[12] 黎伟强. 胺碘酮联合琥珀酸美托洛尔对慢性心力衰竭合并快室率心房颤动临床观察[J] . 中国循证心血管医学杂志，2016，8(2):189191.
[13] 姚魁武，陈孟倩，刘甜甜,等. 参附注射液辅助治疗对冠心病慢性心力衰竭患者生活质量及生存情况的影响[J] . 中医杂志，2016，57(24):21172120.
[14] 蔡 镇. 中药人参煎剂对慢性心力衰竭患者心功能及血浆脑钠肽水平的影响[J] . 中医药信息，2016，33(1):5659. 
[15] 戴小华，花继平. 益气温阳活血利水法对慢性心力衰竭患者心功能及N端前脑钠肽、超敏C反应蛋白的影响[J] . 现代中西医结合杂志，2016，25(17):18311833.
[16] 田国芳,宋玉勤,张丽花,等.参芪复脉汤加减联合常规西医治疗慢性心力衰竭合并低血压状态疗效观察[J] .河北中医,2017,39(9):13401343.

备注/Memo

备注/Memo:
*河南省中医药科学研究专项（ 2015ZY02087）
更新日期/Last Update: 2019-03-13